Surgery Partners Stock Forecast, Price & News

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Surgery Partners stock.
View analyst ratings for Surgery Partners or view top-rated stocks.

Wall Street analysts have given Surgery Partners a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Surgery Partners wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Surgery Partners.

Surgery Partners will be holding an earnings conference call on Wednesday, May 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Surgery Partners, Inc. (NASDAQ:SGRY) announced its earnings results on Tuesday, March, 9th. The company reported $0.09 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.02 by $0.07. The company had revenue of $548.30 million for the quarter. Surgery Partners had a negative net margin of 7.64% and a negative trailing twelve-month return on equity of 4.73%.
View Surgery Partners' earnings history.

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SGRY shares have increased by 370.7% and is now trading at $41.70.
View which stocks have been most impacted by COVID-19.

Surgery Partners updated its first quarter 2021 Pre-Market earnings guidance on Tuesday, April, 20th. The company provided EPS guidance of for the period. The company issued revenue guidance of $505 million, compared to the consensus revenue estimate of $495.83 million.

7 brokers have issued 1 year target prices for Surgery Partners' shares. Their forecasts range from $17.50 to $54.00. On average, they expect Surgery Partners' share price to reach $31.07 in the next year. This suggests that the stock has a possible downside of 25.5%.
View analysts' price targets for Surgery Partners or view top-rated stocks among Wall Street analysts.

7 employees have rated Surgery Partners CEO Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among Surgery Partners' employees.

Some companies that are related to Surgery Partners include Tenet Healthcare (THC), Community Health Systems (CYH), SunLink Health Systems (SSY), Nobilis Health (HLTH), First Physicians Capital Group (FPCG), Ethema Health (GRST) and Rennova Health (RNVA).
View all of SGRY's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR).

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.17%) and Hennessy Advisors Inc. (0.12%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Jason Eric Evans and Teresa Deluca.
View institutional ownership trends for Surgery Partners.

SGRY stock was bought by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., and Calamos Advisors LLC. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans, and Teresa Deluca.
View insider buying and selling activity for Surgery Partners or or view top insider-buying stocks.

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SGRY stock can currently be purchased for approximately $41.70.

Surgery Partners has a market capitalization of $2.50 billion and generates $1.83 billion in revenue each year. The company earns $-74,800,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis.

Surgery Partners employs 9,100 workers across the globe.

The official website for Surgery Partners is www.surgerypartners.com.

Surgery Partners is headquartered at 310 Seven Springs Way Suite 500, Brentwood TN, 37027.

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]